(Q42673590)

English

An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables

scientific article published on March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

based on heuristic

inferred from title

Christoph Gerlinger

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

author name string

Jan Endrikat

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

C Klipping

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

M Cronin

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

A Ruebig

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

W Schmidt

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

B Düsterberg

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

215-221

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900316-X

7 January 2021

A review of ‘once-a-month's combined injectable contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900316-X

7 January 2021

A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900316-X

7 January 2021

Large observational trial of a new low-dose oral contraceptive containing 20 micrograms ethinylestradiol and 100 micrograms levonorgestrel (Miranova) in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900316-X

7 January 2021

Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900316-X

7 January 2021

A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900316-X

7 January 2021

Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900316-X

7 January 2021

Importance of levonorgestrel dose in oral contraceptives for effects on coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900316-X

7 January 2021

Ethinylestradiol 20 versus 30 micrograms combined with 150 micrograms desogestrel: a large comparative study of the effects of two low-dose oral contraceptives on the hemostatic system

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900316-X

7 January 2021

A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 mu(g) ethinylestradiol and either 2 mg chlormadinone acetate or 150 mu(g) desogestrel

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900316-X

7 January 2021

Blood coagulation and oral contraceptives. A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900316-X

7 January 2021

An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900316-X

7 January 2021

Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900316-X

7 January 2021

Low-dose combined oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900316-X

7 January 2021

Insulin resistance, secretion, and metabolism in users of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2801%2900316-X

7 January 2021

Identifiers

10.1016/S0010-7824(01)00316-X

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42673590&oldid=1965193070"